Olema Pharmaceuticals
OLMA
OLMA
91 hedge funds and large institutions have $155M invested in Olema Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
49% less call options, than puts
Call options by funds: $179K | Put options by funds: $351K
57% less capital invested
Capital invested by funds: $359M → $155M (-$204M)
Holders
91
Holding in Top 10
–
Calls
$179K
Puts
$351K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$2.39M | |
| 3 | +$1.09M | |
| 4 |
Renaissance Technologies
New York
|
+$1.05M |
| 5 |
Goldman Sachs
New York
|
+$972K |
Top Sellers
| 1 | -$7.64M | |
| 2 | -$7.01M | |
| 3 | -$4.39M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.25M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.11M |